These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32976980)

  • 21. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy.
    Osta WA; Chen Y; Mikhitarian K; Mitas M; Salem M; Hannun YA; Cole DJ; Gillanders WE
    Cancer Res; 2004 Aug; 64(16):5818-24. PubMed ID: 15313925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by AP1-dependent EpCAM expression in MCF-7 cells.
    Gao J; Yan Q; Wang J; Liu S; Yang X
    J Cell Physiol; 2015 Apr; 230(4):775-82. PubMed ID: 25205054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EpCAM and the biology of hepatic stem/progenitor cells.
    Dollé L; Theise ND; Schmelzer E; Boulter L; Gires O; van Grunsven LA
    Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G233-50. PubMed ID: 25477371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EpCAM: another surface-to-nucleus missile.
    Carpenter G; Red Brewer M
    Cancer Cell; 2009 Mar; 15(3):165-6. PubMed ID: 19249674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis.
    Spizzo G; Fong D; Wurm M; Ensinger C; Obrist P; Hofer C; Mazzoleni G; Gastl G; Went P
    J Clin Pathol; 2011 May; 64(5):415-20. PubMed ID: 21415054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microparticles from ovarian carcinomas are shed into ascites and promote cell migration.
    Press JZ; Reyes M; Pitteri SJ; Pennil C; Garcia R; Goff BA; Hanash SM; Swisher EM
    Int J Gynecol Cancer; 2012 May; 22(4):546-52. PubMed ID: 22315094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Claudin-7 regulates EpCAM-mediated functions in tumor progression.
    Nübel T; Preobraschenski J; Tuncay H; Weiss T; Kuhn S; Ladwein M; Langbein L; Zöller M
    Mol Cancer Res; 2009 Mar; 7(3):285-99. PubMed ID: 19276185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and role of epithelial cell adhesion molecule in dysplastic nodule and hepatocellular carcinoma.
    Bae JS; Noh SJ; Jang KY; Park HS; Chung MJ; Park CK; Moon WS
    Int J Oncol; 2012 Dec; 41(6):2150-8. PubMed ID: 22993038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EpCAM and its potential role in tumor-initiating cells.
    Imrich S; Hachmeister M; Gires O
    Cell Adh Migr; 2012; 6(1):30-8. PubMed ID: 22647938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deglycosylation of epithelial cell adhesion molecule affects epithelial to mesenchymal transition in breast cancer cells.
    Liu X; Yang L; Zhang D; Liu T; Yan Q; Yang X
    J Cell Physiol; 2019 Apr; 234(4):4504-4514. PubMed ID: 30246502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel function of EpCAM in oral squamous cell carcinoma cells under anchorage-independent conditions.
    Inoue H; Ohnishi Y; Nakajima M; Kakudo K; Nozaki M
    Int J Oncol; 2011 Dec; 39(6):1401-5. PubMed ID: 21785818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors.
    Rao CG; Chianese D; Doyle GV; Miller MC; Russell T; Sanders RA; Terstappen LW
    Int J Oncol; 2005 Jul; 27(1):49-57. PubMed ID: 15942643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EpCAM: a potential antimetastatic target for gastric cancer.
    Du W; Ji H; Cao S; Wang L; Bai F; Liu J; Fan D
    Dig Dis Sci; 2010 Aug; 55(8):2165-71. PubMed ID: 19941073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EpCAM duality becomes this molecule in a new Dr. Jekyll and Mr. Hyde tale.
    Herreros-Pomares A; Aguilar-Gallardo C; Calabuig-Fariñas S; Sirera R; Jantus-Lewintre E; Camps C
    Crit Rev Oncol Hematol; 2018 Jun; 126():52-63. PubMed ID: 29759567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-negative feedback loop between EpCAM and ERK contributes to the regulation of epithelial-mesenchymal transition in cancer.
    Sankpal NV; Fleming TP; Sharma PK; Wiedner HJ; Gillanders WE
    Oncogene; 2017 Jun; 36(26):3706-3717. PubMed ID: 28192403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy.
    Yanamoto S; Kawasaki G; Yoshitomi I; Iwamoto T; Hirata K; Mizuno A
    Oral Oncol; 2007 Oct; 43(9):869-77. PubMed ID: 17207659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic EpCAM expression on circulating and disseminating tumor cells: causes and consequences.
    Gires O; Stoecklein NH
    Cell Mol Life Sci; 2014 Nov; 71(22):4393-402. PubMed ID: 25103341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the EpCAM (CD326) in prostate cancer metastasis and progression.
    Ni J; Cozzi PJ; Duan W; Shigdar S; Graham PH; John KH; Li Y
    Cancer Metastasis Rev; 2012 Dec; 31(3-4):779-91. PubMed ID: 22718399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B-cell receptor-associated protein 31 regulates human embryonic stem cell adhesion, stemness, and survival via control of epithelial cell adhesion molecule.
    Kim WT; Seo Choi H; Min Lee H; Jang YJ; Ryu CJ
    Stem Cells; 2014 Oct; 32(10):2626-41. PubMed ID: 24898727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MMP7 is a target of the tumour-associated antigen EpCAM.
    Denzel S; Mack B; Eggert C; Massoner P; Stöcklein N; Kemming D; Harréus U; Gires O
    Int J Exp Pathol; 2012 Oct; 93(5):341-53. PubMed ID: 22974215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.